UPV spin off receives one million euros for the development of ACORYS, a medical device designed to improve the effectiveness and treatment of Atrial Fibrillation.

Corify Care, a spin off company of the Polytechnic University of Valencia (UPV), has obtained a one million euros grant from the Research and Development Centre for Industrial Technology Development (CDTI) of the Spanish Ministry of Science and Innovation.

This grant will be destinated for the development of ACORYS, a medical device that, using technology created by the Hospital General Universitario Gregorio Marañón and the UPV, enhances the effectiveness and non-invasive treatment of atrial fibrillation, a cardiac arrhythmia that affects more than 10 million people just across Europe.

Related posts

Last week, Corify Care was invited to participate in the XXI Course of ablation and navigation systems at the Instituto de Investigación...

We are proud to announce that Corify has been awarded funding from two Torres Quevedo programs, a major recognition of our innovative...

Our CEO, Andreu M. Climent was invited to Life Science Intelligence Summit 2024 (LSI Europe24) in Sintra (Portugal), an event that convenes...